BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 19621668)

  • 1. Little necessity of acid inhibition against proton pump inhibitor rebound effects and prior helicobacter pylori eradication therapy in gastric ulcer patients: a randomized prospective study.
    Wada Y; Ito M; Takata S; Kitamura S; Takamura A; Tatsugami M; Imagawa S; Matsumoto Y; Tanaka S; Yoshihara M; Chayama K
    Hepatogastroenterology; 2009; 56(91-92):624-8. PubMed ID: 19621668
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early development of reflux esophagitis after successful Helicobacter pylori eradication in superficial gastritis.
    Huh JH; Park MS; Jeon HH
    JNMA J Nepal Med Assoc; 2011; 51(184):189-91. PubMed ID: 22922899
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is Helicobacter pylori eradication associated with gastroesophageal reflux disease?
    Fallone CA; Barkun AN; Friedman G; Mayrand S; Loo V; Beech R; Best L; Joseph L
    Am J Gastroenterol; 2000 Apr; 95(4):914-20. PubMed ID: 10763937
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sofalcone, a gastroprotective drug, promotes gastric ulcer healing following eradication therapy for Helicobacter pylori: a randomized controlled comparative trial with cimetidine, an H2-receptor antagonist.
    Higuchi K; Watanabe T; Tanigawa T; Tominaga K; Fujiwara Y; Arakawa T
    J Gastroenterol Hepatol; 2010 May; 25 Suppl 1():S155-60. PubMed ID: 20586860
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Helicobacter pylori eradication therapy may facilitate gastric ulcer healing after endoscopic mucosal resection: a prospective randomized study.
    Cheon JH; Kim JH; Lee SK; Kim TI; Kim WH; Lee YC
    Helicobacter; 2008 Dec; 13(6):564-71. PubMed ID: 19166423
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Long-term course of reflux symptoms following Helicobacter pylori eradication].
    Peitz U; Raps S; Plein K; Leodolter A; Hotz Dagger J; Malfertheiner P
    Dtsch Med Wochenschr; 2004 Mar; 129(13):671-5. PubMed ID: 15026962
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Symptomatic benefit 1-3 years after H. pylori eradication in ulcer patients: impact of gastroesophageal reflux disease.
    McColl KE; Dickson A; El-Nujumi A; El-Omar E; Kelman A
    Am J Gastroenterol; 2000 Jan; 95(1):101-5. PubMed ID: 10638566
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Does H. pylori infection or its eradication play a role in gastroeosphageal reflux disease?].
    Zerbib F
    Gastroenterol Clin Biol; 2003 Mar; 27(3 Pt 2):427-31. PubMed ID: 12700499
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of Helicobacter pylori eradication on the anti-secretory efficacy of lansoprazole in gastroesophageal reflux disease patients.
    Giral A; Celikel CA; Ozdogan O; Tözün N; Ulusoy NB; Kalayci C
    J Gastroenterol Hepatol; 2005 Dec; 20(12):1886-91. PubMed ID: 16336449
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GERD and H. pylori: is there a link?
    Falk GW
    Semin Gastrointest Dis; 2001 Jan; 12(1):16-25. PubMed ID: 11215851
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of cure of Helicobacter pylori infection on gastric acidity and gastroesophageal reflux: study by 24-h pH monitoring in patients with gastric or duodenal ulcer.
    Fukuchi T; Ashida K; Yamashita H; Kiyota N; Tsukamoto R; Takahashi H; Ito D; Nagamatsu R
    J Gastroenterol; 2005 Apr; 40(4):350-60. PubMed ID: 15870971
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Usefulness of proton pump inhibitor (PPI) maintenance therapy for patients with H. pylori-negative recurrent peptic ulcer after eradication therapy for H. pylori: pathophysiological characteristics of H. pylori-negative recurrent ulcer scars and beyond acid suppression by PPI.
    Ohara T; Morishita T; Suzuki H; Masaoka T; Ishii H
    Hepatogastroenterology; 2004; 51(56):338-42. PubMed ID: 15086153
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Helicobacter pylori and gastroesophageal reflux disease: friends or foes?
    Gisbert JP; Pajares JM; Losa C
    Hepatogastroenterology; 1999; 46(26):1023-9. PubMed ID: 10370661
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative assessment of gastric corpus atrophy in subjects using omeprazole: a randomized follow-up study.
    van Grieken NC; Meijer GA; Weiss MM; Bloemena E; Lindeman J; Baak JP; Meuwissen SG; Kuipers EJ
    Am J Gastroenterol; 2001 Oct; 96(10):2882-6. PubMed ID: 11693321
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Helicobacter pylori eradication may induce de novo, but transient and mild, reflux esophagitis: Prospective endoscopic evaluation.
    Take S; Mizuno M; Ishiki K; Nagahara Y; Yoshida T; Yokota K; Oguma K; Okada H; Yamamoto K
    J Gastroenterol Hepatol; 2009 Jan; 24(1):107-13. PubMed ID: 18823429
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The roles of Helicobacter pylori and pattern of gastritis in the pathogenesis of reflux esophagitis].
    Gao BX; Duan LP; Wang K; Xia ZW; Lin SR
    Zhonghua Yi Xue Za Zhi; 2006 Oct; 86(38):2674-8. PubMed ID: 17199974
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Helicobacter pylori infection, reflux esophagitis, and atrophic gastritis: an unexplored triangle.
    Xia HH; Talley NJ
    Am J Gastroenterol; 1998 Mar; 93(3):394-400. PubMed ID: 9517647
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Helicobacter pylori and nonmalignant diseases.
    Kuipers EJ; Malfertheiner P
    Helicobacter; 2004; 9 Suppl 1():29-34. PubMed ID: 15347303
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of Helicobacter pylori eradication on development of erosive esophagitis and gastroesophageal reflux disease symptoms: a post hoc analysis of eight double blind prospective studies.
    Laine L; Sugg J
    Am J Gastroenterol; 2002 Dec; 97(12):2992-7. PubMed ID: 12492181
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Maintenance treatment is not necessary after Helicobacter pylori eradication and healing of bleeding peptic ulcer: a 5-year prospective, randomized, controlled study.
    Liu CC; Lee CL; Chan CC; Tu TC; Liao CC; Wu CH; Chen TK
    Arch Intern Med; 2003 Sep; 163(17):2020-4. PubMed ID: 14504114
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.